Description

ARA 290 (16mg) is a synthetic peptide derived from erythropoietin (EPO) but designed to act only on tissue-protective pathways without stimulating red blood cell production. It has been studied for its potential to reduce inflammation, nerve pain, and tissue damage, while supporting healing and recovery. Research highlights its possible role in conditions involving neuropathic pain, diabetes-related complications, and autoimmune disorders. ARA 290 is valued for its anti-inflammatory and tissue-protective properties, making it a promising candidate in the field of regenerative and immune support therapies.